Organization
Beth Isreal Deaconess Medical Center, Harvard Medical School, Boston, United States of America
1 abstract
Abstract
BIOMARKER PROFILING REVEALS NOVEL MECHANISTIC INSIGHTS INTO USTEKINUMAB THERAPEUTIC RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUSOrg: Janssen Research and Development, LLC, Spring House, United States of america, AMPEL BioSolutions, LLC, Charlottesville, United States of America, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, University of California, Los Angeles, Los Angeles, United States of America, Beth Isreal Deaconess Medical Center, Harvard Medical School, Boston, United States of America,